Programmed cell death antagonist protein

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S320100, C435S325000, C435S252300, C435S254110, C435S069200, C536S023100, C536S023200, C536S023500, C536S063000, C536S024310

Reexamination Certificate

active

06623937

ABSTRACT:

FIELD OF THE INVENTION
The invention relates to proteins involved in the prevention of programmed cell death, namely programmed cell death antagonist (PCDA) proteins.
BACKGROUND OF THE INVENTION
Cells become specified during development through sequential restriction of their potential fates. This process includes mechanisms that monitor differentiation to eliminate, by programmed cell death, cells that have inappropriate specificity or developmental capacity, or that are extraneous (Glucksmann,
Biol Rev.
26:59-86 (1951); Saunders,
Science
154:604-612 (1966)). Many aspects of tissue development rely on cell death for the selection of proper sets of cells. For example, in vertebrates, massive numbers of neurons generated in early development become eliminated in late stage refinement of connections (Hamburger et al.,
J. Exp. Zool.
111:457-502 (1949); Oppenheim,
Ann. Rev. Neurosci.
14:453-501 (1991)). The mechanism is thought primarily to occur through competition for trophic agents derived from target tissues, which may reinforce appropriate patterns of innervation. Similarly, in the immune system, progenitor cells must generate a great diversity of cell types. The differentiation process relies heavily on regulated cell death to eliminate large numbers of cells of inappropriate reactivity (Fesus,
Immunol. Lett.
30:277-282 (1991); Goldstein et al.,
Immunol. Rev.
121:29-65 (1991)).
The mechanisms and regulation of programmed cell death have a number of implications. For example, the regulation of programmed cell death has implications for oncogenesis (Williams,
Cell
65 1097-1098 (1991)), immune disease (Ameisen et al.,
Immunol. Today
12:102-105 (1991); Meyaard et al.,
Science
257:217-219 (1992)), and conditions where excessive cell death results in tissue damage, such as neural injury (Choi,
Neuron
1:623-634 (1988)). Neural and immune system development also display important programmed cell death events. In insects, some cell death is observed early, during neuroblast delamination in the formation of the ventral nerve cord (Doe et al.,
Dev. Biol.
111:193-205 (1985); Jimènez and Campos-Ortega,
Neuron
5:81-89 (1990)). In vertebrates, cell death that is not associated with target innervation is observed in the spinal ganglia (Hamburger et al., supra; Pannese,
Neuropathol. Appl. Neurobiol.
2:247-267 (1976); Hamburger et al.,
J. Neurosci.
1:60-71 (1981); Carr et al.,
Dev. Brain Res.
2:157-162 (1982)). Administration in vivo of nerve growth factor prevents nerve cell death (Hamburger et al., supra), suggesting that competition for factors may participate in the selection of neural cells even at early developmental stages. Progenitor cells of the oligodendrocyte lineage also require certain levels of survival factors during early development (Barres et al.,
Cell
70:31-46 (1992)). The types of factors that influence cell survival may change as the cells mature (Barres et al., supra), suggesting that different signals may be involved in the selection of cells at different developmental stages. In the immune system, the elimination of cells through cell death functions at multiple stages. T cell maturation may involve two types of selection processes. Cells lacking appropriate receptors fail to be positively selected for further differentiation and are eliminated (Sha et al.,
Nature
336:73-76 (1988); Teh et al.,
Nature
335:229-233 (1988)). Cells that do develop receptors but are self-reactive are also eliminated (Kappler et al.,
Nature
332:35-40 (1988); MacDonald et al.,
Nature
332:40-45 (1988); Smith et al.,
Nature
337:181-184 (1989). Regulated cell death thus appears to function together with selection to sculpt an appropriate repertoire of cells.
Programmed cell death typically occurs in conjunction with critical differentiation events. Recent work suggests that programmed cell death is a default fate that will occur unless actively inhibited (Barres et al., supra; Raff,
Nature
356:397-400 (1992). In addition, studies done in
C. elegans
imply that the differentiation pathway and the cell death pathway may be uncoupled genetically (Ellis et al.,
Cell
44:817-829 (1986); Hengartner et al.,
Nature
356:495-499 (1992). Genes that function in the cell death pathway have been identified, such as the ced genes of
Caenorhabditis elegans
(Ellis et al., supra; Hengartner et al., supra). However, genes are also needed to determine when during development that pathway is activated. To coordinate differentiation and death, the activities of genes involved in select differentiation events presumably impinge on control of genes of the death pathway to repress the suicide of appropriate cells.
The Drosophila eye is an excellent genetic system for approaching the problem of how differentiation events and cell death interplay to achieve proper cellular development (Ready,
Trends Neurosci.
12:102-110 (1989); Banerjee et al.,
Neuron
4:177-187 (1990); Rubin,
Trends Genet.
7:372-377 (1991)). The adult eye is composed of some 800 repeated neural units called ommatidia, each containing cell types that include three photoreceptor classes, three kinds of pigment cells, cone cells, and a bristle cell complete with socket, neuron, and glial sheath. During the third larval instar, progenitor cells commence differentiation to generate the various cell types (Waddington et al.,
Proc. Roy. Soc. Lond.
(
B
) 153:155-178 (1960)). Differentiation is marked by a morphogenetic furrow that moves from posterior to anterior across the field of progenitor cells in the eye portion of the eye-antennal imaginal disc (Ready et al.,
Dev. Biol.
53:217-240 (1976)). Anterior to the morphogenetic furrow, the progenitor cells undergo division to generate an epithelial field for the differentiation events that commence with the furrow. Thus, at a given time, the disc displays a time line of development, the earliest morphologically evident differentiation events being associated with the furrow. Later events occur toward the posterior of the disc, where a pattern emerges of developing cell clusters. Little is known about the events before furrow formation that lead to differentiation, although cell competence, hormones, and possibly inductive interactions appear to be involved (Bodenstein,
Postembryotic Development,
in
Insect Physiology
, K. D. Roeder, ed. New York, Wiley & Sons, Inc. pp 822-865 (1953); White,
J. Exp. Zool.
148:223-239 (1961); Gateff et al.,
Roux's Arch. Dev. Biol.
176:171-189 (1975). Some cell death is a normal part of the developmental process, having been observed in the eye disc during morphogenesis (Fristrom,
Mol. Gen. Genet.
103:363-379 (1969); Spreij,
Neth. J. Zool.
21:221-264 (1971); Wolff et al.,
Development
113:825-839 (1991)).
One mutation, eya, has proven useful in the study of eye development. Flies with the eya
1
mutation show remarkable specificity for loss of the adult compound eyes (
FIGS. 1A and 1B
; Sved,
Dros Inf. Serv.
63:169 (1986); Renfranz et al.,
Dev. Biol.
136:411-429 (1989)). All other external structures appear normal, including the adult ocelli, which develop from edges of the eye imaginal discs. In the brain, there is loss of the first optic ganglion (lamina) and reduction in size of the second optic ganglion (medulla), and the lobula and lobula plate show some disorganization (FIGS.
1
C and
1
D). These brain defects are similar to those observed in other eyeless mutants and are consistent with the influence of retinal neurons on development of the optic lobes (Power,
J. Exp. Zool.
94:33-71 (1943); Meyerowitz et al.,
Dev. Biol.
62:112-142 (1978); Fischbach,
Dev. Biol.
91:1-18 (1983); Selleck et al.,
Neuron
6:83-99 (1991).
In normal development, eye differentiation begins during the third instar larval stage when the morphogenetic furrow sweeps from posterior to anterior across the eye portion of the eye-antennal disc, leaving clusters of differentiating photoreceptor neurons in its wake (Ready et al., supra). The differentiating clusters can be visualized by staining with monoclonal antibodies, suc

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Programmed cell death antagonist protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Programmed cell death antagonist protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Programmed cell death antagonist protein will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3044835

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.